News

Your contact person

Manager PR & Communications Jan Phillip Denkers

There is no vaccine for Bundibugyo virus, and treatment consists of supportive care. This makes it all the more important to identify the problem quickly and reliably so that the necessary steps can be taken without delay. Photo: CDC/Dr. Frederick Murphy
There is no vaccine for Bundibugyo virus, and treatment consists of supportive care. This makes it all the more important to identify the problem quickly and reliably so that the necessary steps can be taken without delay. (Photo: CDC/Dr. Frederick Murphy)

Ebola virus detection by altona Diagnostics kits

The World Health Organization (WHO) has officially declared the Ebola outbreak in the Democratic Republic of the Congo (DRC) and Uganda a Public Health Emergency ...

Read more …
The technology transfer was successfully completed at the 1500 L scale at Phyton Biotech’s GMP facilities near Hamburg, Germany (Fermentation) and in Vancouver, Canada (Purification). (Image: Phyton Biotech)
The technology transfer was successfully completed at the 1500 L scale at Phyton Biotech’s GMP facilities near Hamburg, Germany (Fermentation) and in Vancouver, Canada (Purification). (Image: Phyton Biotech)

Phyton Biotech Completes Corallopyronin A Technology Transfer

Phyton Biotech has successfully transferred the manufacturing process for the microbial production of Corallopyronin A (CorA). CorA is a novel anti-infective agent with the potential ...

Read more …
The Hamburg iGEM team at this year's student competition for synthetic biology in Paris. (Image: Laurenz Stammel)
The Hamburg iGEM team at this year's student competition for synthetic biology in Paris. From left to right, front row: Evangelos Masis, Lucy Jansen, Kristina Boneß. From left to right, back row: Joel Martins Ribeiro, Ole Hunke, Mariia Vvedenskaia, Marius Beßler, Laurenz Stammel, Milo Krömer. (Image: Laurenz Stammel)

iGEM Hamburg Team Awarded Gold Medal

With their project “DeathCapTrap,” the iGEM Hamburg team developed an antidote to one of the most dangerous fungal toxins in the world. They were awarded ...

Read more …
More than fifty researchers, industrial and community partners will gather from several European countries to give start to this ambitious cross-sectoral, public-private research partnership. (Image: Viromarkers)
More than fifty researchers, industrial and community partners will gather from several European countries to give start to this ambitious cross-sectoral, public-private research partnership. (Image: Viromarkers)

altona industrial leader in Viromarkers research project

altona Diagnostics is part of the Viromarkers project, a European research initiative dedicated to advancing virus-related biomarkers for the management of chronic infections, which officially ...

Read more …
At the end of September, researchers and other stakeholders from the HALRIC network met in Hamburg to plan and discuss future collaborations. (Picture: UHH/Feurerböter)
At the end of September, researchers and other stakeholders from the HALRIC network met in Hamburg to plan and discuss future collaborations. (Picture: UHH/Feurerböter)

HALRIC gathers 100 people in Hamburg

On 24-25 September over 100 people attended HALRIC’s conference at the Bahrenfeld Campus in Hamburg. The first day kicked off with a high-level panel session, ...

Read more …
Left to right: Dr. Erik Bogsch, Daniel Ambrock, Daniel Günther, Dr. Kai Pohlmeyer, Erik Bogsch
Left to right: Dr. Erik Bogsch – Head of the Biotechnology Business Unit, Daniel Ambrock - Mayor of Bovenau, Daniel Günther - Minister-President of the State of Schleswig-Holstein, Dr. Kai Pohlmeyer - CEO, Erik Bogsch – Lifetime Honorary Chairman (Picture: Richter BioLogics)

Richter BioLogics triples production capacity

Richter BioLogics GmbH & Co KG, the microbial biologics affiliate of Gedeon Richter Plc. celebrated the opening of ...

Read more …
Moving forward, the Omics Hub will continue to serve as a key resource for clinicians and clinical network partners in order to drive novel research and ultimately improve personalized oncology and the treatment of patients.
Moving forward, the Omics Hub will continue to serve as a key resource for clinicians and clinical network partners in order to drive novel research and ultimately improve personalized oncology and the treatment of patients. (Image: Screenshot/Discover Oncology)

Indivumed: New Publication in Discover Oncology

Indivumed GmbH announced the fourth research publication enabled by the Indivumed Omics Hub. An interface for members of the Indivumed Global Clinical Network, the Omics ...

Read more …
(Picture: © Cellbox Solutions)

Cellbox 2.0 released

Cellbox Solutions is proud to launch the Cellbox 2.0 - the next generation of transportable incubators showcasing added features, improvements, ...

Read more …

Evotec: strategic roadmap towards precision medicine

Evotec SE presents at its virtual Capital Markets Day how artificial intelligence (“AI”) and machine learning (“ML”) enabled precision technologies in discovery ...

Read more …
Pharmacy and medicine also benefit from the knowledge gained from both fundamental and applied aquaculture research. (Picture: © Entwicklungsgesellschaft Westholstein (egw))

German Society for Marine Aquaculture & Fraunhofer IMTE

Aquaculture is a growing market around the world. From animal feed production and food manufacturing to pharmaceuticals and medicine, a wide range of industries are ...

Read more …
The innovative solutions for the transport of living cells are now also available on the market in the USA. (Image: ©Cellbox Solutions GmbH)

Cellbox Solutions Establishes Subsidiary in the USA

Cellbox Solutions GmbH, developer of the patented Cellbox technology, has founded their U.S. company and is now selling products directly to the U.S./North American market. ...

Read more …

Evotec SE reports results for the first quarter 2021

Evotec SE today announced the financial results and corporate updates for the first quarter 2021. ...

Read more …